Fehlkauf und Überbestände durch mangelnde Bestandstransparenz
Definition
The case study explicitly documents: 'Chemicals were purchased centrally, but scientists did not review or update any information on storage, use, or disposal. This resulted in excessive chemical purchasing' and 'chemicals listed as available but missing at critical times.' The search results emphasize that with proper visibility, companies can 'see what final products you have on hand, ensuring you don't manufacture or build things already in stock.' Manual FIFO systems fail because information is scattered across spreadsheets, storeroom labels, and operator memory—creating forecast errors and poor capital allocation.
Key Findings
- Financial Impact: €20,000–€60,000/year in excessive/duplicate chemical purchases; 3–7% inventory write-off due to overstock; 10–20 hours/month manual inventory inquiry/reconciliation labor
- Frequency: Monthly (purchasing decisions); Quarterly (inventory reviews)
- Root Cause: Absence of centralized, real-time inventory database; no automated alerts for 'stock available but not yet consumed'; manual reconciliation delays between warehouse, lab, and production; FIFO enforcement only as a checklist, not a system constraint
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Artificial Rubber and Synthetic Fiber Manufacturing.
Affected Stakeholders
Procurement, Finance/Cost Accounting, Production Planning, Warehouse
Action Plan
Run AI-powered research on this problem. Each action generates a detailed report with sources.
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.